Osteoarthritis pain has a significant neuropathic component: An exploratory in vivo patient model

Rheumatology International

Volumn 34, Issue 3, 2014, Pages 315-320

  Duarte, Rui V ^a,b   Raphael, Jon H ^a,b   Dimitroulas, Theodoros ^b   Sparkes, Elizabeth ^c   Southall, Jane L ^b   Ashford, Robert L ^a   Kitas, George D ^b  

^a BIRMINGHAM CITY UNIVERSITY   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

^c Faculty of Engineering and Computing   (United Kingdom)

Author keywords

Intravenous lignocaine; Neuropathic pain; Osteoarthritis; Pain intensity

Indexed keywords

LIDOCAINE;

ADULT; AGED; ANALGESIA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; COPING BEHAVIOR; DEPENDENT PERSONALITY DISORDER; DISEASE SEVERITY; DRUG EFFICACY; EXPLORATORY RESEARCH; FEMALE; HOUSEHOLD; HUMAN; IN VIVO STUDY; JOINT MOBILITY; MALE; MIDDLE AGED; NEUROPATHIC PAIN; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RHEUMATOLOGY; SLEEP; SOCIAL LIFE;

ADULT; AGED; ANESTHETICS, LOCAL; ARTHRALGIA; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEURALGIA; OSTEOARTHRITIS; PAIN MANAGEMENT; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84896723038     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2893-y     Document Type: Article

References (29)

1. Arden N, Nevitt MC (2006) Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 20(1):3-25
2. Felson DT (2005) Relation of obesity and of vocational and avocational risk factors to osteoarthritis. J Rheumatol 32(6):1133-1135
3. Dray A, Read SJ (2007) Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther 9(3):212
4. Bjordal JM, Ljunggren AE, Klovning A, Slørdal L (2004) Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 329(7478):1317
5. Neame R, Zhang W, Doherty M (2004) A historic issue of the annals: three papers examine paracetamol in osteoarthritis. Ann Rheum Dis 63(8):897-900
6. Catterall WA (2002) Molecular mechanisms of gating and drug block of sodium channels. Novartis Found Symp 241:206-218
7. Kastrup J, Petersen P, Dejgård A, Angelo HR, Hilsted J (1987) Intravenous lidocaine infusion: a new treatment of chronic painful diabetic neuropathy? Pain 28(1):69-75
8. Rowbotham MC, Reisner-Keller LA, Fields HL (1991) Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41(7):1024-1028
9. Mao J, Chen LL (2000) Systemic lidocaine for neuropathic pain relief. Pain 87(1):7-17
10. Burch F, Codding C, Patel N, Sheldon E (2004) Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial. Osteoarthr Cartil 12(3):253-255
11. Gammaitoni AR, Galer BS, Onawola R, Jensen MP, Argoff CE (2004) Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 20(suppl 2):S13-S19
12. Loughnan TE, Taverner MG, Webb A (2009) Randomized, double blinded comparative trial of intradermal injections of lignocaine versus N-saline around the knee to relieve pain in patients awaiting total knee replacement. Clin J Pain 25(4):269-272
13. Altman RD (1991) Criteria for classification of clinical osteoarthritis. J Rheumatol Suppl 27:10-12
14. Raphael JH, Southall JL, Kitas GD (2003) Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. Rheumatology 42(1):185-186
15. Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1-2):9-19
16. Cohen J (1992) A power primer. Psychol Bull 112(1):155-159
17. Dworkin RH, Turk DC, Wyrwich KW et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9(2):105-121
18. Koppert W, Zeck S, Sittl R, Likar R, Knoll R, Schmelz M (1998) Low-dose lidocaine suppresses experimentally induced hyperalgesia in humans. Anesthesiology 89(6):1345-1353
19. Koppert W, Ostermeier N, Sittl R, Weidner C, Schmelz M (2000) Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain 85(1-2):217-224
20. Dray A (2008) New horizons in pharmacologic treatment for rheumatic disease pain. Rheum Dis Clin N Am 34(2):481-505
21. Hochman JR, French MR, Bermingham SL, Hawker GA (2010) The nerve of osteoarthritis pain. Arthrit Care Res 62(7):1019-1023
22. Im H, Kim J, Li X et al (2010) Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 62(10):2995-3005
23. Zhang W, Doherty M, Leeb BF et al (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 66(3):377-388
24. Felson DT, Lawrence RC, Hochberg MC et al (2000) Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med 133(9):726-737
25. Wandel S, Jüni P, Tendal B et al (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 341:c4675
26. Hawker GA (2009) Experiencing painful osteoarthritis: what have we learned from listening? Curr Opin Rheumatol 21(5):507-512
27. Rosemann T, Laux G, Szecsenyi J, Wensing M, Grol R (2008) Pain and osteoarthritis in primary care: factors associated with pain perception in a sample of 1,021 patients. Pain Med 9(7):903-910
28. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M (2008) The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 67(12):1716-1723
29. Raphael JH, Southall JL, Treharne GJ, Kitas GD (2002) Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskelet Disord 3:21